Evidence map›Paper›PMID 34915152›Full record

ArticleNeurobiology of disease2022

ALS-linked cytoplasmic FUS assemblies are compositionally different from physiological stress granules and sequester hnRNPA3, a novel modifier of FUS toxicity.

Haiyan An, Gioana Litscher, Naruaki Watanabe, Wenbin Wei, Tadafumi Hashimoto, Takeshi Iwatsubo, Vladimir L Buchman, Tatyana A Shelkovnikova

Open access · goldAbstract read
In one paragraph

Article in Neurobiology of disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Exploring dysregulated miRNAs in ALS: implications for disease pathogenesis and early diagnosis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Aging RNA granule dynamics in neurodegeneration.Frontiers in molecular biosciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Haiyan AnMedicines Discovery Institute, Cardiff University, Cardiff CF10 3AT, United Kingdom.
Gioana LitscherMedicines Discovery Institute, Cardiff University, Cardiff CF10 3AT, United Kingdom.
Naruaki WatanabeDepartment of Neuropathology, University of Tokyo, Tokyo, Japan.
Wenbin WeiDepartment of Biosciences, Durham University, Durham DH1 3LE, United Kingdom.
Tadafumi HashimotoDepartment of Neuropathology, University of Tokyo, Tokyo, Japan.
Takeshi IwatsuboDepartment of Neuropathology, University of Tokyo, Tokyo, Japan.
Vladimir L BuchmanSchool of Biosciences, Cardiff University, Cardiff CF10 3AX, United Kingdom; Belgorod State National Research University, Belgorod 308015, Russian Federation.
Tatyana A ShelkovnikovaMedicines Discovery Institute, Cardiff University, Cardiff CF10 3AT, United Kingdom. Electronic address: t.shelkovnikova@sheffield.ac.uk.
Cardiff University · GBThe University of Tokyo · JPDurham University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Formation of cytoplasmic RNA-protein structures called stress granules (SGs) is a highly conserved cellular response to stress. Abnormal metabolism of SGs may contribute to the pathogenesis of (neuro)degenerative diseases such as amyotrophic lateral sclerosis (ALS). Many SG proteins are affected by mutations causative of these conditions, including fused in sarcoma (FUS). Mutant FUS variants have high affinity to SGs and also spontaneously form de novo cytoplasmic RNA granules. Mutant FUS-containing assemblies (mFAs), often called "pathological SGs", are proposed to play a role in ALS-FUS pathogenesis. However, structural differences between mFAs and physiological SGs remain largely unknown therefore it is unclear whether mFAs can functionally substitute for SGs and how they affect cellular stress responses. Here we used affinity purification to isolate mFAs and physiological SGs and compare their protein composition. We found that proteins within mFAs form significantly more physical interactions than those in SGs however mFAs fail to recruit many factors involved in signal transduction. Furthermore, we found that proteasome subunits and certain nucleocytoplasmic transport factors are depleted from mFAs, whereas translation elongation, mRNA surveillance and splicing factors as well as mitochondrial proteins are enriched in mFAs, as compared to SGs. Validation experiments for a mFA-specific protein, hnRNPA3, confirmed its RNA-dependent interaction with FUS and its sequestration into FUS inclusions in cultured cells and in a FUS transgenic mouse model. Silencing of the Drosophila hnRNPA3 ortholog was deleterious and potentiated human FUS toxicity in the retina of transgenic flies. In conclusion, we show that SG-like structures formed by mutant FUS are structurally distinct from SGs, prone to persistence, likely cannot functionally replace SGs, and affect a spectrum of cellular pathways in stressed cells. Results of our study support a pathogenic role for cytoplasmic FUS assemblies in ALS-FUS.

Indexed as

Amyotrophic Lateral SclerosisAnimalsCytoplasmInclusion BodiesMiceMutationRNA-Binding Protein FUSStress GranulesStress, PhysiologicalRNA-Binding Protein FUSALSFUSFUS aggregatehnRNPA3ProteomicsRNP granuleSG coreStress granule

Identifiers

PMID34915152
PMCPMC8799889
OpenAlexW4200273654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.